Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly

Stroke

Volumn 28, Issue 11, 1997, Pages 2219-2221

  Yamada, Masahito ^a   Sodeyama, Nobuyuki ^a   Itoh, Yoshinori ^b   Suematsu, Naomi ^b   Otomo, Eiichi ^b   Matsushita, Masaaki ^c   Mizusawa, Hidehiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Yokufukai Geriatric Hospital   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; Amyloid; Elderly; Polymorphism (genetics)

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BRAIN BLOOD FLOW; DISEASE SEVERITY; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; JAPAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

EID: 0030710512     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.11.2219     Document Type: Article

References (24)

1. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke. 1987;18:311-324.
2. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol. 1987;234:371-376.
3. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci. 1993:116;135-141.
4. Greenberg SG, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38:254-259.
5. Premkumar DRD, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996;148:2083-2095.
6. Itoh Y, Yamada M, Suematsu N, Matsushita M, Otomo E. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke. 1996;27:216-218.
7. Nicoll JAR, Burnett C., Love S, Graham DI, Ironside JW, Vinters HV. High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1996;39:682.
8. Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E. Lack of an association between apolipoprotein E ε4 and cerebral amyloid angiopathy in elderly Japanese. Ann Neurol. 1996;39:683.
9. Sherrington R, Rogaev EI, Liang Y, Rogaev EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov Y, Pollen DA, Roses AD, Frase PE, Rommens JM, St Geroge-Hyslop PH. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375: 754-760.
10. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Vitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 1996;2:864-870.
11. Lemere CA, Lopera F, Kosik K, Lendon CL, Ossa, J, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, Hincapie L, Juan Carlos Arango L, Anthony DC, Koo EH, Goate AM, Selkoe DJ, Juan Caralos Arango V. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 1996;2:1146-1150.
12. Duff K, Eckman C, Zehr C, Yu X, Prada C-M, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996;383:710-713.
13. Wragg M, Hutton M, Talbot C, for the Alzheimer's Disease Collaborative Group. Genetic association between intronic polymorphism in presenlin-1 gene and late-onset Alzheimer's disease. Lancet. 1996;347:509-512.
14. Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ, and the UK Alzheimer's Disease Collaborative Group. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 1996;347:1185. Letter.
15. Higuchi S, Muramatsu T, Matsushita S, Arai H, Sasaki H. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 1996; 347:1186. Letter.
16. Scott WK, Growdon JH, Roses AD, Haines JL, Pericak-Vance MA. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 1996;347:1186-1187. Letter.
17. Pérez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier-Harlin M-C, the Alzheimer's Study Group. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 1996;347:1560-1561. Letter.
18. Kehoe P, Williams J, Holmans P, Liddell M, Lovestone S, Holmes C, Powell J, Neal J, Wilcock G, Owen MJ. Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease. Neuroreport. 1996;7:2155-2158.
19. Mann DMA, Pickering-Brown SM, Bayatti NN, Wright AE, Owen F, Iwatsubo T, Saido TC. An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid β protein deposited in Alzheimer's disease. Neurosci Lett. 1997;222:57-60.
20. Tysoe C, Whittaker J, Cairns NJ, Atkinson PF, Harrington, CR, Xuereb J, Wilcock G, Rubinsztein DC. Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci Lett. 1997;222:68-69.
21. Mirra S, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, and Participating CERAD Neuropathologists. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
22. Mori H, Takio K, Ogawara M, Selkoe DJ. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem. 1992;267:17082-17086.
23. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
24. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res. 1990;31:545-548.